Table 2.
Outcomes of 150 Patients Who Underwent Cardiovascular Implantable Electronic Device Deactivation
| Deactivation |
||||
|---|---|---|---|---|
| Outcome | All Patients | Tachycardia Therapies Only (n = 118) | Bradycardia Therapies With or Without Tachycardia Therapies (n = 32) | P Value |
| Survival, No. (%)a | ||||
| Dead | 146 (97) | 114 (97) | 32 (100) | .58 |
| Alive | 4 (3) | 4 (3) | 0 (0) | |
| Survival after deactivation, median (range), d | 2 (0-483) | 3 (0-483) | 0 (0-60) | <.001 |
| Deaths after deactivation, No. (%)b | ||||
| 1 d | 40 (27) | 23 (19) | 17 (53) | <.001 |
| 1 wk | 106 (71) | 78 (66) | 28 (88) | .04 |
| 1 mo | 130 (87) | 100 (85) | 30 (94) | .52 |
| 1 y | 145 (97) | 113 (96) | 32 (100) | >.99 |
| 2 y | 146 (97) | 114 (97) | 32 (100) | >.99 |
a
As of September 1, 2012.
b
Within the time frame noted.